Lentivirus-mediated knockdown of tumor protein D52-like 2 inhibits glioma cell proliferation
- PMID: 24842331
Lentivirus-mediated knockdown of tumor protein D52-like 2 inhibits glioma cell proliferation
Abstract
TPD52L2 (tumor protein D52-like 2) is a member of TPD52 family which has been implicated in multiple human cancers. Recently, TPD52 protein was shown to be associated with several malignancies, but very little is known about the function of TPD52L2 in cancers, especially in glioma to date, and its roles in glioma occurrence and progression remain to be elucidated. In the present study, we employed lentivirus-mediated RNA interference (RNAi) to knock down TPD52L2 expression in human glioma cell line U251. We found that knockdown of TPD52L2 significantly not only inhibited cell proliferation and colony formation, but also induced G0/G1 cell cycle arrest in vitro. Taken together, these findings suggest that TPD52L2 might play an important role in glioma tumorigenesis.
Similar articles
-
Knockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma.Cell Biol Int. 2015 Mar;39(3):264-71. doi: 10.1002/cbin.10388. Epub 2014 Oct 13. Cell Biol Int. 2015. Retraction in: Cell Biol Int. 2016 Mar;40(3):361. doi: 10.1002/cbin.10593. PMID: 25262828 Retracted.
-
Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.Neurol Res. 2014 Jul;36(7):659-65. doi: 10.1179/1743132813Y.0000000298. Epub 2013 Dec 19. Neurol Res. 2014. PMID: 24620959
-
Tumor protein D52-like 2 contributes to proliferation of breast cancer cells.Cancer Biother Radiopharm. 2015 Feb;30(1):1-7. doi: 10.1089/cbr.2014.1723. Epub 2015 Jan 28. Cancer Biother Radiopharm. 2015. Retraction in: Cancer Biother Radiopharm. 2017 Dec;32(10):387. doi: 10.1089/cbr.2014.1723.retract. PMID: 25629696 Free PMC article. Retracted.
-
Preclinical support for tumor protein D52 as a cancer vaccine antigen.Hum Vaccin Immunother. 2023 Dec 15;19(3):2273699. doi: 10.1080/21645515.2023.2273699. Epub 2023 Oct 30. Hum Vaccin Immunother. 2023. PMID: 37904517 Free PMC article. Review.
-
Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Tumour Biol. 2014 Aug;35(8):7369-82. doi: 10.1007/s13277-014-2006-x. Epub 2014 May 6. Tumour Biol. 2014. PMID: 24798974 Review.
Cited by
-
Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.Oncotarget. 2016 Mar 22;7(12):13730-41. doi: 10.18632/oncotarget.7316. Oncotarget. 2016. PMID: 26883192 Free PMC article.
-
The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions.Biomark Insights. 2019 Feb 5;14:1177271919829162. doi: 10.1177/1177271919829162. eCollection 2019. Biomark Insights. 2019. PMID: 30783377 Free PMC article. Review.
-
The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress In Vitro.Evid Based Complement Alternat Med. 2022 Jan 18;2022:4451178. doi: 10.1155/2022/4451178. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35087592 Free PMC article.
-
Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach.Biomed Res Int. 2019 May 21;2019:5268031. doi: 10.1155/2019/5268031. eCollection 2019. Biomed Res Int. 2019. PMID: 31240215 Free PMC article.
-
DNA methylation in lung tissues of mouse offspring exposed in utero to polycyclic aromatic hydrocarbons.Food Chem Toxicol. 2017 Nov;109(Pt 1):703-713. doi: 10.1016/j.fct.2017.04.047. Epub 2017 May 2. Food Chem Toxicol. 2017. PMID: 28476633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous